Search Results
Results found for "Esther Martinborough"
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
recognition motifs for the MRGPRD GPCR Chunyu Wang , Yongfeng Liu , Marion Lanier , Brian K Shoichet , Esther Martinborough , Jonathan F Fay , Can Cao , Bryan L Roth , et al.
- Structural landscape of the Chemokine Receptor system
Esther 2023). The 30s-loop of chemokines can bind either on top of the extracellular loop 2 (ECL2) or inside the major
- Conjugation Strategies for Probe Development
byproduct obtained by the O-acylisourea rearranging intramolecularly into the N-acylurea.[ 2] NHS ester NHS esters are not very stable even in aqueous environment but they only need a slightly basic medium
- Co-activation of GPCRs facilitate GIRK-dependent current
Activation of either D2 or GABAB receptors also acutely desensitized the GIRK channel current induced Results demonstrate that the activity of either G protein-coupled receptor system must be considered
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
and isolation of A2AAR and assembly of A2AAR in lipid nanodiscs and procedures for incorporation of either
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
and isolation of A2AAR and assembly of A2AAR in lipid nanodiscs and procedures for incorporation of either
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers These dimeric forms, which can either be transient or stable, are believed to influence the function
- G protein-coupled receptor 21 in macrophages: An in vitro study
THP-1 cells were activated and differentiated into either M1 or M2 macrophages.
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
These can be used either as stand-alone therapeutics or to improve the safety profile of opioid drugs
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
This session unpacks how persistent binding can either accelerate your program—or quietly kill it. Why Tight Binding Isn’t Always Good News When a drug won’t let go, you can’t either.
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
from behavioral and physiological studies implying that bias toward or against D1-mediated β-arrestin either
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
substitution of one amino acid by another in a protein can have effects ranging from negligible to dramatic, either Through either random or targeted (site-directed) approaches, mutagenesis can provide a comprehensive
- Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
The temporal signals could implicate either GPCR/14-3-3 complex dissociation or the complex undergoing
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
evidence supporting the use of various drugs including orthosteric and allosteric ligands acting on either
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
(AHH) is a rare disease caused by calcium-sensing receptor (CaSR) autoantibodies, to date, showing either
- Canonical chemokine receptors as scavenging “decoys”
Indeed, ACKRs behave as scavenging “decoys” in order to either limit chemokines spatial availability
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
The inhibition of either internalization or mitochondria-targeting of Hst1 could significantly compromise
- Why “Displacement” Misleads You: Allosteric Binding Demystified
The Allosteric Shift: When Receptors Become Something New In orthosteric pharmacology, a ligand is either
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
Cells Are Highly Dynamic during Collagen-Induced Arthritis "The sympathetic nervous system (SNS) has either
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
Transfected HEK-293 cells were assessed for Ca2+o -stimulated Ca2+i mobilization using mutations in either
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
Activation of melatonin MT2 receptors with either pharmacological concentrations of melatonin (10-100
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
visualization and quantification of SST2/SST5 dimerization in rat GH3 as well as in human melanoma cells either
- Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...
Small-interfering RNA (siRNA) technology was also used to knockdown either ROCK1 or ROCK2.
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
libraries typically leads to the isolation of several hundred candidate hits, enriched because they either the ensemble of candidate hits provides a rich resource of information to inform lead optimization, either agonists with different levels of signaling activity, biased agonists that preferentially activate either The cytotoxic drug Monomethyl auristatin E (MMAE) was used alone or conjugated to either the native CCL5
- VAMP2: a crucial player in the delivery of MOR to the synapse
different fusion proteins and also this different molecular codes will be modulated by different opioids, either
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Furthermore, understanding these resistance mechanisms enables the design of next-generation drugs that either
- Targeting Intracellular Allosteric Sites in GPCRs
/inverse agonism, where the allosteric modulator can perturb receptor signaling in a manner that is either
- Odorant receptors – a bit of smell for drug discovery
The development of antibodies directed towards an OR could either drive receptor inactivation or activation
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
chemokine receptors (ACKRs) which do not couple to G proteins and behave as scavenging “decoys” in order to either
- Glyco-sulfo hotspots in the chemokine receptor system
Chemokine receptors have either reported or predicted sites of N-acetyl galactosamine (GalNAc)-type O-glycosylation







